X2V73Q7Restriction of Coronary Sinus with Reduction Device, Percutaneous Approach, New Technology Group 7
- Billable / Specific Code
X2V73Q7 is a billable ICD-10-PCS procedure code for Restriction of Coronary Sinus with Reduction Device, Percutaneous Approach, New Technology Group 7. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026) and groups to MS-DRGs 228, 229. The root operation Restriction involves partially closing an orifice or the lumen of a tubular body part.
Code Identity
PCS Table Breakdown
Each ICD-10-PCS code is built from seven characters, each an axis of the procedure. Hover or tap the icons for the official CMS definitions.
| Position | Designation | Value | Meaning |
|---|---|---|---|
| 1 | Section | X | New Technology |
| 2 | Body System | 2 | Cardiovascular System |
| 3 | Operation | V | Restriction |
| 4 | BodyPart | 7 | Coronary Sinus |
| 5 | Approach | 3 | Percutaneous |
| 6 | Device/Substance/Technology | Q | Reduction Device |
| 7 | Qualifier | 7 | New Technology Group 7 |
Code History
- 02H43DZ — Insertion of Intralum Dev into Cor Vein, Perc Approach
Similar Procedure Codes
Questions About X2V73Q7
Is X2V73Q7 a billable code?
Yes. X2V73Q7 is a complete seven-character ICD-10-PCS code, specific enough to report Restriction of Coronary Sinus with Reduction Device, Percutaneous Approach, New Technology Group 7 on inpatient claims from October 1, 2025 through September 30, 2026.
What do the characters in X2V73Q7 mean?
X2V73Q7 breaks down character by character: the 1st character X is the Section (New Technology); the 2nd character 2 is the Body System (Cardiovascular System); the 3rd character V is the Operation (Restriction); the 4th character 7 is the BodyPart (Coronary Sinus); the 5th character 3 is the Approach (Percutaneous); the 6th character Q is the Device/Substance/Technology (Reduction Device); the 7th character 7 is the Qualifier (New Technology Group 7).
What MS-DRG does X2V73Q7 group to?
On an inpatient stay, Restriction of Coronary Sinus with Reduction Device, Percutaneous Approach, New Technology Group 7 maps to MS-DRGs 228, 229, with relative weights from 3.1495 to 4.9474. The MS-DRG sets the fixed Medicare payment for the stay.
